Dishman Carbogen Amcis (DCAL) is planning to invest $ 50 million in France to set up a new facility for manufacturing formulated products, mainly in the form of parenterals. The new facility would begin commercial production from January 2023 with two manufacturing lines.
Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.